ABBVIE BIOTECH VENTURES
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.
ABBVIE BIOTECH VENTURES
Industry:
Biotechnology Financial Services Venture Capital
Founded:
2013-01-01
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Tag Manager Apache COVID-19 Google Optimize 360 Amazon Elastic Load Balancing Sticky Session Amazon ALB SEO_H2 Adobe Experience Manager
Similar Organizations
BlueStone Venture Partners
BlueStone Venture Partners is a life science venture capital fund investing in entrepreneurial companies.
Current Employees Featured
Scott Brun Head @ AbbVie Biotech Ventures
Head
John Gustofson Managing Director @ AbbVie Biotech Ventures
Managing Director
2016-04-01
Jay Cui Manager @ AbbVie Biotech Ventures
Manager
Margarita Chavez Managing Director @ AbbVie Biotech Ventures
Managing Director
2016-01-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-06 | AmbAgon Therapeutics | AbbVie Biotech Ventures investment in Series A - AmbAgon Therapeutics | 85 M USD |
| 2021-11-02 | Nitrase Therapeutics | AbbVie Biotech Ventures investment in Series A - Nitrase Therapeutics | 7 M USD |
| 2021-10-26 | Quanta Therapeutics | AbbVie Biotech Ventures investment in Series C - Quanta Therapeutics | 60 M USD |
| 2021-08-18 | Jnana Therapeutics | AbbVie Biotech Ventures investment in Series B - Jnana Therapeutics | 50 M USD |
| 2021-08-17 | Starday Foods | AbbVie Biotech Ventures investment in Seed Round - Starday Foods | 4 M USD |
| 2021-07-15 | Stemson Therapeutics | AbbVie Biotech Ventures investment in Series A - Stemson Therapeutics | 15 M USD |
| 2021-06-14 | Ribon Therapeutics | AbbVie Biotech Ventures investment in Series C - Ribon Therapeutics | 65 M USD |
| 2021-03-03 | Caribou Biosciences | AbbVie Biotech Ventures investment in Series C - Caribou Biosciences | 115 M USD |
| 2021-03-01 | Carisma Therapeutics | AbbVie Biotech Ventures investment in Series B - Carisma Therapeutics | 12 M USD |
| 2021-01-07 | Carisma Therapeutics | AbbVie Biotech Ventures investment in Series B - Carisma Therapeutics | 47 M USD |
More informations about "AbbVie Biotech Ventures"
AbbVie Ventures Portfolio | AbbVie - Pharmaceutical Research
AbbVie Ventures is focused on early-stage opportunities in oncology, immunology, neuroscience, eye care, and aesthetics. ... FireCyte is an emerging biotechnology company developing novel … See details»
A Commitment to Supporting Leading Innovators Globally - AbbVie
2 AbbVie Ventures 2024 Year-In-Review 3 AbbVie Ventures is dedicated to investing in science, people and ecosystems to shape tomorrow’s cures, driven by today’s innovators. The year 2024 … See details»
AbbieVie Ventures » LaunchBio event
Mar 28, 2024 Calling all early-stage biotech and novel therapeutics companies! AbbVie Ventures is the strategic venture arm of AbbVie, with the mission to invest in transformational scientific … See details»
AbbVie - Crunchbase Company Profile & Funding
AbbVie is a biopharmaceutical company that develops pharmaceuticals and medical devices. The company provides products and services to therapeutic areas including immunology, oncology, … See details»
Funding Research & Development with AbbVie Ventures - Excedr
AbbVie’s Approach to R&D: Focus Areas. AbbVie Ventures funds the development and delivery of innovative medicines and therapeutics that have the potential to improve patients’ lives. The 75% … See details»
AbbVie Ventures - Profile
AbbVie Biotech Ventures supports transformational scientific opportunities aligned with AbbVie's core R&D interests to gain access to next-generation … See details»
Abbvie Biotech Ventures - Private Equity List
Abbvie Biotech Ventures. Investor type. CVC. Founded. 2013. AUM-Location. United States. $0-1 m. Investment Ticket. ... We’re AbbVie’s corporate strategic venture capital arm Investing since … See details»
AbbVie Biotech Ventures Investor Information - Funding, Portfolio ...
AbbVie Biotech Ventures is a venture capital fund concentrating on biotech and deep tech sectors. They invest in early-stage companies to develop impactful medicines and solutions for complex … See details»
How AbbVie aims to transform lives with early-stage …
Fig. 1 | AbbVie Ventures’ focus areas supporting research and development investment. ADC, antibody–drug conjugate; BBB, blood–brain barrier; CAR, … See details»
AbbVie Ventures Portfolio Investments, AbbVie Ventures Funds, …
Jan 8, 2024 AbbVie Ventures is a corporate venture arm of AbbVie dedicated to making venture capital investments in emerging biotech and pharmaceutical companies. The firm invests globally … See details»
Partner with Us | AbbVie - Pharmaceutical Research & Development
Oct 24, 2024 AbbVie Ventures We strategically invest in transformational scientific opportunities to augment our core R&D interests and gain access to next-generation science and proven scientific … See details»
AbbVie Biotech Ventures | IT History Society
AbbVie Biotech Ventures, an Illinois-based company, makes investments in emerging biotech and pharmaceutical companies.AbbVie is a global, research-based biopharmaceutical company … See details»
Investing to Develop Tomorrow's Cures by Today's Entrepreneurs
To reinforce our reputation as partner of choice, AbbVie Ventures engaged with innovation ecosystems globally to source investment opportunities. Mitokinin: Regular engagement with … See details»
Abbvie Biotech Ventures company information, funding & investors
Abbvie Biotech Ventures. Save Request enhancement Edit profile. Save. Abbvie Biotech Ventures. Save Request enhancement Edit profile. Save. Makes investments in emerging biotech and … See details»
AbbVie Biotech Ventures Venture Capital Profile | VentureDeal
AbbVie Biotech Ventures, Inc. (ABVI) is a subsidiary of AbbVie dedicated to making venture capital investments in emerging biotech and pharmaceutical companies. Unlike traditional venture capital … See details»
Brain health startup to join SpinUp as first AbbVie Biotech Innovators ...
4 days ago A biotech startup tackling brain diseases is joining University of Toronto Mississauga’s SpinUp incubator as the inaugural winner of the AbbVie Biotech Innovators Award. Neuropeutics … See details»
AbbVie taps oncology research org for aid running diverse trials
5 days ago AbbVie is looking south to boost its community-based clinical trials. The Chicago-area pharma giant is partnering with Nashville-based Sarah Cannon Research Institute to run diverse … See details»
abbvie
*Partnering 2030: The Biotech Perspective – 2022 Report Partnering has always been an integral part of AbbVie's success. AbbVie's decade of impact ... AbbVie Ventures: Visit … See details»
Our Company - AbbVie
At AbbVie, we combine advanced science, expertise and passion to solve serious health issues and have a remarkable impact on people’s lives. ... Signed and dated letter of request on your … See details»
AbbVie stakes $335M on a startup’s RNAi drugs | BioPharma Dive
May 15, 2025 AbbVie is staking hundreds of millions of dollars on RNA interference, agreeing on Wednesday to work with biotechnology startup ADARx Pharmaceuticals to develop experimental … See details»